ClinicalTrials.govpublic full text
PD-L1 ImagiNg to prediCt Durvalumab Treatment Response in HNSCC
head and neck cancer, durvalumab, pd-l1 imaging, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 882677
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.